POST ASH22 transplant summary Published 2023-01-19 Download video MP4 360p Download video MP4 720p Recommendations 44:15 Management of Chronic Myeloid Leukemia (CML) in special populations 59:44 MD vs Machine: How Artificial Intelligence Will Transform Medicine 39:49 Imetelstat in patients with lower-risk MDS 2:04:47 De-novo drug design, Reaction based enumeration, combinatorial library design 2:25:55 HMS/HSDM White Coat Ceremony 1:32:45 Turning Fear into Power: Understanding and managing anxiety - Longwood Seminar 2:24:07 2023 HMS/HSDM White Coat Ceremony 53:18 Diabetic Kidney disease 2024 by Dr. Anas Alyousif 1:23:46 MD vs. Machine: Artificial intelligence in health care 35:59 Guidelines for dyslipidemia management of type 2 diabetes – new directions? 58:18 KURS EKG - Część 1 1:27:19 The Art of Aging Well 1:31:24 It's All In Your Head — Longwood Seminar 43:48 Post transplantation Cyclophosphamide Based Graft-versus-Host Disease Prophylaxis 39:47 PNH: New Therapeutic Update 1:12:04 Multiple Myeloma: a post-ASH22 summary 1:16:04 Post ASH23 Myeloma roundtable by the IACH 1:49:56 Basics of Ligand-based Drug Design: 3D-QSAR and Pharmacophore modeling approaches 54:02 Management of High-Risk Chronic Lymphocytic Leukemia 55:02 Acute and Late Toxicities of Bi-specific Antibody Therapy Similar videos 43:39 POST ASH22 MPN summary 47:26 POST ASH22 MDS summary 1:15:00 POST ASH22 cellular therapy 1:38:24 Post #ASH21 by the IACH: Hematopoietic Cell Transplantation 08:42 ASH 22 | AL amyloidosis highlights 03:14 ASH 22 | Myeloma XI clinical trial 1:54:37 THE iach post #ASH22 take-home messages in Leukemia, Lymphoma and Myeloma 1:04:39 Best of ASH22 AML 1:06:13 Latest Advances in Multiple Myeloma a post ASH 2020 Summary 01:36 ASH 22 | Dr Dimopoulos' perspective on the myeloma highlights presented at ASH 2022 1:04:39 Allogeneic stem cell transplantation for older patients: where do we stand? 2:02:31 Drs. Munshi, Bahlis, & Ghobrial discuss #MultipleMyeloma at #ASH22 - http://bit.ly/3FH1LxK 28:15 Management of T-ALL: an update 43:10 Venetoclax Plus Gilteritinib for FLT3-Mutated Relapsed/Refractory Acute Myeloid Leukemia 33:19 MDS - Myeloplastic Syndromes - 2023 Best of Hematology Conference 02:00 Real-world outcomes of autoSCT for multiple myeloma in the first-line setting 02:49 Highlights in AL amyloidosis from ASH 2022: EMN22, EMN27 & predictors of hematologic CR 01:33 The role of allogeneic transplantation in patients with multiple myeloma More results